A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) given intravenously in patients with advanced solid tumours
Banerji, U Evans, J Candilejo, M Roxburgh, P Kelly, Claire Sabaratnam, N Passi, R Leslie, S Katugampola, S
Banerji, U
Evans, J
Candilejo, M
Roxburgh, P
Kelly, Claire
Sabaratnam, N
Passi, R
Leslie, S
Katugampola, S
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Banerji U, Cook N, Evans T, Candilejo I, Roxburgh P, Kelly C, et al. A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) given intravenously in patients with advanced solid tumours. Br J Cancer. 2018;119(11):42.